HR-MAS NMR Tissue Metabolomic Signatures Cross-Validated by Mass Spectrometry Distinguish Bladder Cancer from Benign Disease

Effective diagnosis and surveillance of Bladder Cancer (BCa) is currently challenged by detection methods that are of poor sensitivity, particularly for low-grade tumors, resulting in unnecessary invasive procedures and economic burden. We performed HR-MAS NMR-based global metabolomic profiling and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tripathi, Pratima, Somashekar, Bagganahalli S, Ponnusamy, M., Gursky, Amy, Dailey, Stephen, Kunju, Priya, Lee, Cheryl T., Chinnaiyan, Arul M., Rajendiran, Thekkelnaycke M., Ramamoorthy, Ayyalusamy
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3722911/
https://ncbi.nlm.nih.gov/pubmed/23731241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/pr4004135
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados